4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
1.64%
↑ 100% above average
Average (30q)
-13081.31%
Historical baseline
Range
High:100.79%
Low:-342500.00%
Volatility
-2619.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 1.64% |
| Q2 2025 | -342500.00% |
| Q1 2025 | 100.79% |
| Q4 2024 | -59533.33% |
| Q3 2024 | 100.01% |
| Q2 2024 | -14.41% |
| Q1 2024 | -6.89% |
| Q4 2023 | -435.73% |
| Q3 2023 | 79.17% |
| Q2 2023 | -5.57% |
| Q1 2023 | -9.19% |
| Q4 2022 | -9.83% |
| Q3 2022 | 8.98% |
| Q2 2022 | -11.55% |
| Q1 2022 | -4.16% |
| Q4 2021 | -20.46% |
| Q3 2021 | -2151.01% |
| Q2 2021 | 94.03% |
| Q1 2021 | 20.71% |
| Q4 2020 | -228.54% |
| Q3 2020 | 65.80% |
| Q2 2020 | -25.61% |
| Q1 2020 | 6.84% |
| Q4 2019 | -16.92% |
| Q3 2019 | -40.57% |
| Q2 2019 | 0.00% |
| Q1 2019 | -1049.95% |
| Q4 2018 | 0.00% |
| Q3 2018 | 65.18% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |